Staffing Pressures And Real Estate Risks Will Restrain Long Term Earnings Recovery

Catalysts

About emeis Société anonyme

emeis Société anonyme operates nursing homes and healthcare facilities across several European markets.

What are the underlying business or industry changes driving this perspective?

• Rising care needs over the next decade could require significant capacity and staffing investment. If wage inflation or regulatory staffing ratios move against the group, the current focus on optimizing staff costs may be hard to sustain and could pressure EBITDA margins and net income.
• The creation of the new real estate company concentrates a large pool of assets in a single vehicle and relies on preferred equity economics. If healthcare real estate values soften or fail to revalue as expected, emeis may see less benefit from disposals than anticipated, which could limit future reductions in net debt and leverage.
• Occupancy rates are now close to 88% on the mature perimeter. Any slowdown in the current recovery in France and Germany or a pause in admissions following media or regulatory scrutiny could cap revenue growth while fixed costs remain high, which would weigh on EBIT and cash flow generation.
• The divestment program, already at €2.1b since mid 2022, improves the balance sheet in the near term. If asset sales continue or are extended into weaker transactions to meet debt objectives, the group could reduce its earnings base and narrow the room to grow EBITDA from operations.
• The business plan assumes continued organic growth, revenue CAGR targets to 2028 and ongoing recovery of EBITDA on a like for like basis. Any policy changes around funding of private elderly care or tighter reimbursement frameworks in key markets could limit pricing power and slow the conversion of sales into net margins.

Assumptions

How have these above catalysts been quantified?

• This narrative explores a more pessimistic perspective on emeis Société anonyme compared to the consensus, based on a Fair Value that aligns with the bearish cohort of analysts.
• The bearish analysts are assuming emeis Société anonyme's revenue will grow by 1.9% annually over the next 3 years.
• The bearish analysts are not forecasting that emeis Société anonyme will become profitable in next 3 years. To represent the Analyst Price Target as a Future PE Valuation we will estimate emeis Société anonyme's profit margin will increase from -5.1% to the average GB Healthcare industry of 2.5% in 3 years.
• If emeis Société anonyme's profit margin were to converge on the industry average, you could expect earnings to reach €158.6 million (and earnings per share of €0.98) by about June 2029, up from -€298.4 million today.
• In order for the above numbers to justify the price target of the more bearish analyst cohort, the company would need to trade at a PE ratio of 21.9x on those 2029 earnings, up from -7.7x today. This future PE is greater than the current PE for the GB Healthcare industry at 17.4x.
• The bearish analysts expect the number of shares outstanding to remain consistent over the next 3 years.
• To value all of this in today's terms, we will use a discount rate of 11.55%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?

• Ageing populations in France, Germany and other key markets, combined with management’s comment about a sharp increase in care needs over the next decade, could keep demand for nursing homes and clinics structurally high, which may support occupancy rates and revenue.
• The group is already seeing occupancy around 87% to 88% on the mature perimeter with management expecting the positive trend to continue. If this recovery holds or improves further, higher utilization could support operating leverage and net margins.
• Management reports positive organic revenue growth of 6.2% in H1 2025, EBITDA margin moving from 12.1% to 13.8%, and EBIT returning to a positive €102m. If this trend continues it could translate into improving earnings and cash generation.
• Disposals of around €2.1b since mid 2022 and the new real estate partnership that is expected to reduce net debt to about €3.8b and lower leverage toward 13x suggest a gradual strengthening of the balance sheet, which could ease refinancing risk and support future earnings.
• Free cash flow moving into positive territory at €26m and the sharp reduction in development CapEx, together with stable maintenance and IT CapEx, indicate tighter capital discipline. If this is sustained it could support ongoing free cash flow and improve net income over time.

Valuation

How have all the factors above been brought together to estimate a fair value?

• The assumed bearish price target for emeis Société anonyme is €15.5, which represents up to two standard deviations below the consensus price target of €16.53. This valuation is based on what can be assumed as the expectations of emeis Société anonyme's future earnings growth, profit margins and other risk factors from analysts on the more bearish end of the spectrum.
• However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of €17.5, and the most bearish reporting a price target of just €15.5.
• In order for you to agree with the more bearish analyst cohort, you'd need to believe that by 2029, revenues will be €6.2 billion, earnings will come to €158.6 million, and it would be trading on a PE ratio of 21.9x, assuming you use a discount rate of 11.5%.
• Given the current share price of €14.32, the analyst price target of €15.5 is 7.6% higher. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
• We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.